Health board still paying for research despite criticism over patient benefit

• Betsi Cadwaladr University Health Board continues funding university research partnerships despite ongoing scrutiny regarding demonstrable patient benefit and value for money
• The health board committed £110,686 to support two researchers at Bangor University, raising questions about research prioritisation and resource allocation during NHS funding pressures
• Continued investment in academic research by health boards warrants clearer evidence of clinical translation and patient outcomes to justify expenditure during resource constraints

Betsi Cadwaladr University Health Board was due to pay Bangor University £110,686 for two researchers.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.